Drug Profile
FM OC1
Alternative Names: FM-OC1Latest Information Update: 27 Feb 2019
Price :
$50
*
At a glance
- Originator PharmaLogika
- Class
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Fibromyalgia
Most Recent Events
- 27 Feb 2019 Discontinued - Phase-II for Fibromyalgia in USA (unspecified route)